{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:31:50Z","timestamp":1790947910583,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Like any major operation, sleeve gastrectomy (SG) has its reported postoperative complications. Among them are venous thromboembolic complications (VTE) that may predispose to mortality. Despite the proven efficacy of the traditional anticoagulants, such as low molecular weight heparins (LMWHs) for VTE management, they have their limitations. Direct oral anticoagulants (DOACs) have been currently adopted for the management of VTE. We conducted this study to evaluate the efficacy and safety of apixaban against VTE after laparoscopic sleeve gastrectomy in comparison with LMWH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a randomized controlled trial that included 100 adult patients who underwent SG and received LMWH (Group A) or apixaban (Group B) for VTE prophylaxis. We recorded and analyzed the postoperative events up to the 30th day after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included Group A (n\u2009=\u200950) and Group B (n\u2009=\u200950). No VTE occurred in either group (0%). Postoperative bleeding was encountered in one patient of each group (2%). The follow-up venous Doppler study was unremarkable in the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Apixaban was shown to be comparable to LMWH for the prevention of VTE after LSG with similar efficacy and safety making it a promising alternative to LMWH in patients undergoing bariatric surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11695-025-07721-y","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:42:01Z","timestamp":1739000521000},"page":"934-940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison between low molecular weight heparin and apixaban (direct oral anticoagulant) in the prophylaxis against venous thromboembolism after laparoscopic sleeve gastrectomy"],"prefix":"10.1007","volume":"35","author":[{"given":"Ahmed","family":"Abdelsalam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fikry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Refaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elansary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"7721_CR1","unstructured":"World Obesity Federation. Prevalence of Obesity. Available from: https:\/\/www.worldobesity.org\/about\/about-obesity\/prevalence-of-obesity. Accessed 15 Apr 2021."},{"key":"7721_CR2","first-page":"152","volume":"17","author":"G Markopoulos","year":"2022","unstructured":"Markopoulos G, Skroubis G, Kalfarentzos F, Kehagias I. Comparison of one anastomosis gastric bypass versus standard Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion, in a case-matched, non-superobese population: 6 years of follow-up. Prz Gastroenterol. 2022;17:152\u201361.","journal-title":"Prz Gastroenterol"},{"issue":"11","key":"7721_CR3","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.4240\/wjgs.v13.i11.1509","volume":"13","author":"A Barqawi","year":"2021","unstructured":"Barqawi A, Abushamma FA, Akkawi M, Al-Jabi SW, Shahwan MJ, Jairoun AA, Zyoud SH. Global trends in research related to sleeve gastrectomy: A bibliometric and visualized study. World J Gastrointest Surg. 2021;13(11):1509\u201322.","journal-title":"World J Gastrointest Surg"},{"issue":"5","key":"7721_CR4","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s11695-020-05207-7","volume":"31","author":"L Angrisani","year":"2021","unstructured":"Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L. Bariatric Surgery Survey 2018: Similarities and Disparities Among the 5 IFSO Chapters. Obes Surg. 2021;31(5):1937\u201348.","journal-title":"Obes Surg"},{"issue":"2","key":"7721_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.soard.2010.12.008","volume":"7","author":"DA Winegar","year":"2011","unstructured":"Winegar DA, Sherif B, Pate V, DeMaria EJ. Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2011;7(2):181\u20138.","journal-title":"Surg Obes Relat Dis"},{"issue":"5","key":"7721_CR6","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.soard.2014.12.020","volume":"11","author":"IN Haskins","year":"2015","unstructured":"Haskins IN, Amdur R, Sarani B, Vaziri K. Congestive heart failure is a risk factor for venous thromboembolism in bariatric surgery. Surg Obes Relat Dis. 2015;11(5):1140\u20135.","journal-title":"Surg Obes Relat Dis"},{"issue":"10","key":"7721_CR7","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1381\/096089205774859245","volume":"15","author":"GG Hamad","year":"2005","unstructured":"Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg. 2005;15(10):1368\u201374.","journal-title":"Obes Surg"},{"issue":"2","key":"7721_CR8","first-page":"162","volume":"93","author":"C Hotoleanu","year":"2020","unstructured":"Hotoleanu C. Association between obesity and venous thromboembolism. Med Pharm Rep. 2020;93(2):162\u20138.","journal-title":"Med Pharm Rep"},{"issue":"5","key":"7721_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s11695-012-0854-2","volume":"23","author":"PD Stein","year":"2013","unstructured":"Stein PD, Matta F. Pulmonary embolism and deep venous thrombosis following bariatric surgery. Obes Surg. 2013;23(5):663\u20138.","journal-title":"Obes Surg"},{"issue":"2","key":"7721_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00464-014-3678-4","volume":"29","author":"MH Jamal","year":"2015","unstructured":"Jamal MH, Corcelles R, Shimizu H, Kroh M, Safdie FM, Rosenthal R, Brethauer SA, Schauer PR. Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience. Surg Endosc. 2015;29(2):376\u201380.","journal-title":"Surg Endosc"},{"issue":"2","key":"7721_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.soard.2019.10.025","volume":"16","author":"JI Mechanick","year":"2020","unstructured":"Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists\/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis. 2020;16(2):175\u2013247.","journal-title":"Surg Obes Relat Dis"},{"key":"7721_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.amsu.2020.08.014","volume":"59","author":"W El Ansari","year":"2020","unstructured":"El Ansari W, El-Ansari K. Missing something? A scoping review of venous thromboembolic events and their associations with bariatric surgery. Refining the evidence base. Ann Med Surg (Lond). 2020;59:264\u201373.","journal-title":"Ann Med Surg (Lond)"},{"issue":"7","key":"7721_CR13","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1182\/blood-2014-03-563056","volume":"124","author":"CH Yeh","year":"2014","unstructured":"Yeh CH, Gross PL, Weitz JI. Evolving use of new oral anticoagulants for treatment of venous thromboembolism. Blood. 2014;124(7):1020\u20138.","journal-title":"Blood"},{"key":"7721_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2147\/TCRM.S84210","volume":"11","author":"YH Mekaj","year":"2015","unstructured":"Mekaj YH, Mekaj AY, Duci SB, Miftari EI. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag. 2015;11:967\u201377.","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"7721_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jmv.2014.02.001","volume":"39","author":"S Meddahi","year":"2014","unstructured":"Meddahi S, Samama MM. Caract\u00e9ristiques pharmacologiques et cliniques des inhibiteurs directs du facteur Xa\u202f: rivaroxaban, apixaban, edoxaban et betrixaban [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban]. J Mal Vasc. 2014;39(3):183\u201394.","journal-title":"J Mal Vasc"},{"issue":"9","key":"7721_CR16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.33588\/rn.5709.2013058","volume":"57","author":"C Su\u00e1rez-Fern\u00e1ndez","year":"2013","unstructured":"Su\u00e1rez-Fern\u00e1ndez C, Rold\u00e1n V, Vivancos J. Aspectos practicos de la administracion de rivaroxaban [Practical issues with the use of rivaroxaban]. Rev Neurol. 2013;57(9):411\u201321.","journal-title":"Rev Neurol"},{"key":"7721_CR17","doi-asserted-by":"crossref","unstructured":"Surve A, Potts J, Cottam D, Roslin M, Medlin W, Uchal M, et al. The safety and efficacy of apixaban (Eliquis) in 5017 post-bariatric patients with 95.3% follow-up: a multicenter study. Obes Surg. 2022;32(7):1\u20136.","DOI":"10.1007\/s11695-022-06051-7"},{"issue":"4","key":"7721_CR18","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s11695-024-07100-z","volume":"34","author":"FA Guzman-Pruneda","year":"2024","unstructured":"Guzman-Pruneda FA, Garcia A, Crum RW, Chen T, Krikhely A, Bessler M. Extended Post Discharge Prophylaxis for Venous Thromboembolism Prevention After Bariatric Surgery. Obes Surg. 2024;34(4):1217\u201323.","journal-title":"Obes Surg"},{"issue":"134","key":"7721_CR19","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1182\/blood-2019-127645","volume":"13","author":"M Kushnir","year":"2019","unstructured":"Kushnir M, Gali R, Alexander M, Billett HH. Efficacy and safety of direct oral factor Xa inhibitors in patients after bariatric surgery. Blood. 2019;13(134):2439.","journal-title":"Blood."},{"key":"7721_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000113937","volume":"1","author":"M Fried","year":"2008","unstructured":"Fried M, Hainer V, Basdevant A, Buchwald H, Deitel M, Finer N, et al. Interdisciplinary European guidelines on surgery of severe obesity. Obes Facts. 2008;1:52\u20139.","journal-title":"Obes Facts"},{"key":"7721_CR21","doi-asserted-by":"crossref","unstructured":"Fried M, Yumuk V, Oppert JM, Scopinaro N, Torres A, Weiner R, et al. International Federation for the Surgery of Obesity and Metabolic Disorders\u2014European Chapter (IFSO-EC) and European Association for the Study of Obesity (EASO). Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014;24:42\u201355.","DOI":"10.1007\/s11695-013-1079-8"},{"issue":"6","key":"7721_CR22","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1007\/s00464-020-07555-y","volume":"34","author":"N Di Lorenzo","year":"2020","unstructured":"Di Lorenzo N, Antoniou SA, Batterham RL, Busetto L, Godoroja D, Iossa A, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC. EASO and ESPCOP Surg Endosc. 2020;34(6):2332\u201358.","journal-title":"EASO and ESPCOP Surg Endosc"},{"key":"7721_CR23","doi-asserted-by":"crossref","unstructured":"Caldeira D, Rodrigues FB, Pinto FJ, Ferreira JJ, Costa J. Thromboprophylaxis with apixaban in patients undergoing major orthopedic surgery: meta-analysis and trial-sequential analysis. Clin Med Insights Blood Disord. 2017;10:1179545X17704660.","DOI":"10.1177\/1179545X17704660"},{"issue":"6","key":"7721_CR24","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1097\/CORR.0000000000000749","volume":"477","author":"KH Koo","year":"2019","unstructured":"Koo KH. CORR Insights\u00ae: Postoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry. Clin Orthop Relat Res. 2019;477(6):1344\u20136.","journal-title":"Clin Orthop Relat Res"},{"issue":"9","key":"7721_CR25","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1080\/03007995.2021.1932448","volume":"37","author":"AT Cohen","year":"2021","unstructured":"Cohen AT, Keshishian A, Lee T, Rosenblatt L, Hlavacek P, Sah J, Luo X. Effectiveness and safety of apixaban, LMWH, and warfarin among high-risk subgroups of VTE patients with active cancer. Curr Med Res Opin. 2021;37(9):1467\u201382.","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"7721_CR26","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1308\/rcsann.2020.0209","volume":"102","author":"JI Rodr\u00edguez","year":"2020","unstructured":"Rodr\u00edguez JI, Kobus V, T\u00e9llez I, P\u00e9rez G. Prophylaxis with rivaroxaban after laparoscopic sleeve gastrectomy could reduce the frequency of portomesenteric venous thrombosis. Ann R Coll Surg Engl. 2020;102(9):712\u20136.","journal-title":"Ann R Coll Surg Engl"},{"issue":"2","key":"7721_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1001\/jamasurg.2014.1841","volume":"150","author":"JY Kim","year":"2015","unstructured":"Kim JY, Khavanin N, Rambachan A, McCarthy RJ, Mlodinow AS, De Oliveria GS, Stock MC, Gust MJ, Mahvi DM. Surgical duration and risk of venous thromboembolism. JAMA Surg. 2015;150(2):110\u20137.","journal-title":"JAMA Surg"},{"key":"7721_CR28","unstructured":"American Society of Anesthesiologists and Anesthesia Patient Safety Foundation. ASA and APSF Joint Statement on Elective Surgery and Anesthesia for Patients after COVID-19 Infection. 2022 Feb 22. Available from: https:\/\/www.apsf.org\/news-updates\/asa-and-apsf-joint-statement-on-elective-surgery-and-anesthesia-for-patients-after-covid-19-infection\/"},{"key":"7721_CR29","unstructured":"Centre for Perioperative Care. SARS-CoV-2 infection, COVID-19 and timing of elective surgery. 2021 Mar. Available from: https:\/\/www.cpoc.org.uk\/sites\/cpoc\/files\/documents\/2021-03\/SARS-CoV-2%20infection%2CCOVID-19%20and%20timing%20of%20elective%20surgery.pdf"},{"issue":"7","key":"7721_CR30","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/jamainternmed.2021.0488","volume":"181","author":"NH Roubinian","year":"2021","unstructured":"Roubinian NH, Dusendang JR, Mark DG, Vinson DR, Liu VX, Schmittdiel JA, et al. Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California. JAMA Intern Med. 2021;181(7):997\u20131000.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"7721_CR31","first-page":"e228644","volume":"5","author":"AC Spyropoulos","year":"2022","unstructured":"Spyropoulos AC, Weitz JI, Barnado A, Studt JD, Chan NC, Pai M, et al. Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19. JAMA Netw Open. 2022;5(4):e228644.","journal-title":"JAMA Netw Open"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-07721-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-025-07721-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-07721-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T09:37:14Z","timestamp":1741858634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-025-07721-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7721"],"URL":"https:\/\/doi.org\/10.1007\/s11695-025-07721-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5210609\/v1","asserted-by":"object"}]},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was initiated after approval by the research ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All patients provided informed written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}